Hepatitis B
Clinical Trials:
Title: A Randomized, Double-Blind, Controlled Evaluation of Tenofovir
DF versus Adefovir Dipivoxil for the Treatment of Presumed Pre core Mutant
Chronic Hepatitis B.
Population: Hepatitis B
Coordinator: Fatema
Nader (phone: 703-208-6637)
Status: Closed to enrollment
Title: A Randomized, Double-Blind, Controlled Evaluation of Tenofovir
DF versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic
Hepatitis B.
Population: Hepatitis B
Coordinators: Fatema Nader
(phone: 703-208-6637), Ine-Mari Bornman (Phone:
703-208-6656) or Phuong Lee (Phone:
703-208-6649)
Status: Closed to enrollment
Title: A randomized, double blind, multi-center study comparing
Tenofovir DF, Emtricitabine plus Tenofovir DF, and Entecavir in the treatment of
chronic hepatitis B subject with decompensated liver
disease.
Population: Hepatitis B
Coordinators: Fatema Nader
(phone: 703-208-6637), Ine-Mari Bornman (Phone:
703-208-6656) or Phuong Lee (Phone:
703-208-6649)
Status: Closed to enrollment
Translational Research:
Title: Comparative Analysis of Adipokines and Cytokines in NAFLD,
HCV, and HBV
Population: Non-Alcoholic Fatty Liver Disease (NAFLD),
Hepatitis C (HCV), and Hepatitis B (HBV) patients.
Coordinator: Rochelle
Collantes (phone: 703-208-6659)
Status: Open- not
enrolling
Outcomes Research:
Title: Clinical, Laboratory, and Health-related Quality of Life
(HRQL) of Liver Diseases in Hepatitis B (HBV)
Population: Hepatitis
B patients over 18 years of age who lack evidence of another liver disease, have
not evidence of substance abuse, no evidence of pregnancy, are HIV negative, and
are about to a) start treatment with Adefovir dipivoxil or b) are receiving
standard of care antiviral therapy with their physicians, or c) are not
currently being treated either because they do not qualify for treatment, have
refused treatment, or are not candidates for antiviral therapy.
Coordinator:
Jillian Kallman (703-208-6689)
Status: Open- enrolling.
Title: Survey of Hepatitis B (HBV), Hepatitis C (HCV), and
Non-Alcoholic Fatty Liver.
Disease (NAFLD) Screening Factors Community
Practices Study: A Pilot
Population: GI specialists and Primary Care
Physicians (PCPs)
Coordinator: Jillian Kallman
(703-208-6689)
Status: Open- not currently enrolling
Hours of Operation
Center for Liver Diseases hours of operation:
8:30 a.m. - 5 p.m. Monday -
Friday
Questions?
Contact our office by phone
703-208-6650
or by fax at
703-208-6655
